课题基金 / 基金详情

Orbitrap ID-X Tribrid Mass Spectrometer for Unbiased Global Metabolomics Profiling

Orbitrap ID-X Tribrid Mass Spectrometer for Unbiased Global Metabolomics Profiling
Orbitrap ID-X Tribrid 质谱仪用于无偏全球代谢组学分析
批准号:
10415529
负责人:
Arun Sreekumar
金额:
$78.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-22 至 2023-09-21

项目摘要

项目成果

Arun Sreekumar的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
ABSTRACT The goal of this S10 application is to request funding for a high resolution Orbitrap ID-X Tribrid mass spectrometer (OT IDX) to enable identification and quantification of global metabolite profiles in various biospecimens. This will fill a “missing link” in the Metabolomics Core at Baylor College of Medicine that has to date, excelled in offering targeted metabolic profiling platforms to support scientific investigations. OT IDX will be used to develop robust and well tested methods for profiling steady state levels of metabolites in a global fashion as well as changes in metabolic flux in a global scale. These technologies that will be offered as a new line of service in the Metabolomics Core will support studies using pre-clinical specimens (cell line-derived xenografts, patient-derived xenografts and transgenic models), clinical specimens and cell lines. Importantly, the unbiased technologies will support projects in the areas of Cancer, Diabetes, Obesity, Environmental Exposures, Viral infections, etc. The OT IDX will be administered by the Baylor Metabolomics Core under the Advanced Technology Core Umbrella. The installation, and implementation of OT IDX will be significantly supported by the institutional funding that will cover personnel, Service Contract, software and training costs. The functioning and output of the OT IDX will be monitored by the Internal Advisory Committee and External Advisory Committee, which have experts in metabolomics, Core leaders and institutional representatives. Based on the outstanding track record of the Metabolomics Core at Baylor College of Medicine, the Core is strongly positioned to establish the innovative unbiased global metabolic platform using OT IDX in the institution. This will allow investigators to develop novel hypothesis and leads that could culminate in new biomarkers and novel therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
  • 批准号:
    9888335
  • 项目类别:
  • 资助金额:
    $61.83万
  • 财政年份:
    2019
  • 负责人:
    Arun Sreekumar
  • 依托单位:
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
  • 批准号:
    10232056
  • 项目类别:
  • 资助金额:
    $41.55万
  • 财政年份:
    2019
  • 负责人:
    Arun Sreekumar
  • 依托单位:
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
  • 批准号:
    10674493
  • 项目类别:
  • 资助金额:
    $40.72万
  • 财政年份:
    2019
  • 负责人:
    Arun Sreekumar
  • 依托单位:
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
  • 批准号:
    10474320
  • 项目类别:
  • 资助金额:
    $40.72万
  • 财政年份:
    2019
  • 负责人:
    Arun Sreekumar
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: